The Future of Cancer Care

U.S. Representative Mike Kelly has served in Congress since 2011 and proudly represents Pennsylvania’s 16th District. He grew up in Butler, Pennsylvania, and graduated from Butler High School in 1966, after which he attended the University of Notre Dame on a football and academic scholarship. After college, Rep. Kelly moved back to Butler to work at Kelly Chevrolet-Cadillac, Inc., a company founded by his father in the early 1950s. He took over the dealership in the mid-1990s and expanded its operations to include Hyundai and KIA franchises which altogether currently employ more than 100 people from throughout the region.  Rep. Kelly previously served as a founding board member of the Hyundai “Hope on Wheels” initiative, which to date has donated more than $145 million to childhood cancer research institutions nationwide. He continues to work with the organization as a lawmaker. The Pittsburgh Tribune-Review refers to Rep. Kelly as “Butler’s straight talker” and “a true man of the people.” According to CQ Roll Call, “Any encounter with Kelly has the potential to erupt into a pep rally” thanks to his “gift for enthusiastic – and rapid-fire – communication.” Breitbart News calls Rep. Kelly "a fierce defender of conservatism on Capitol Hill." Fox News Channel’s Neil Cavuto calls him “a key player” and “a mover and shaker” in the U.S. House of Representatives. Rep. Kelly currently sits on the House Ways and Means Committee and is the Chairman of the Subcommittee on Tax.  He and his wife Victoria have four children and are the proud grandparents to ten wonderful grandchildren. Below are just a few of the awards and distinctions that Mike has received while serving Pennsylvania’s 16th District: 60 Plus Association: Guardian of Seniors' Rights Award American Conservative Union: ACU Conservative Award American Farm Bureau Federation: Friend of Farm Bureau Award American International Automobile Dealers: Legislative Action Network Advocacy Award Association of Mature American Citizens: Friend of AMAC Award Family Research Council Action: True Blue Award Hyundai Hope on Wheels: Ambassador of Hope Award International Foodservice Distributers Association: Jefferson Award National Association of Manufacturers: Award for Manufacturing Legislative Excellence National Federation of Independent Business: Guardian of Small Business Award National Retail Federation: Hero of Main Street Award U.S. Chamber of Commerce: Spirit of Enterprise Award

Juan Pablo Uribe is the Global Director for Health, Nutrition and Population at the World Bank and Director of the Global Financing Facility for Women, Children and Adolescents (GFF). Previously, from 2018 to 2019, Dr. Uribe served as Minister of Health and Social Protection of Colombia. Between 2009 and 2011, he was the World Bank´s Health Sector Manager for East Asia and the Pacific. In his vast career, first as a medical doctor specialized in public health and public administration, and later in both public and private leading health sector organizations, Mr. Uribe has contributed significantly to public health policies, health care delivery and health systems development.  

Originally from South Africa, Dr. Catharine Young holds a doctorate degree in Biomedical Sciences and currently serves in the White House Office of Science and Technology Policy. Here she works to advance the Cancer Moonshot - The President and First Lady’s mission to decrease the number of cancer deaths by 50% over the next 25 years. Her focus on cancer began with serving as the Senior Director of Science Policy at the Biden Cancer Initiative (BCI), a non-profit established in 2017 by then former Vice President Biden, leading efforts to bring together the biotech, technology, science, and academic fields to drive innovative solutions and breakthroughs against cancer. Catharine then served as the Executive Director of a Rare Cancer Advocacy organization, where she advanced policy reform and awareness for all rare cancers. Prior to BCI, Catharine served as the Senior Science and Innovation Policy Advisor and Head of the DC team for the Foreign Ministry of the UK. Following her Postdoctoral training at Cornell University in Biomedical Engineering, Catharine was selected as an American Association for the Advancement of Science, Science and Technology Policy Fellow in the Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs. Here she helped lead international engagements on eliminating biological weapons, improving biosafety and biosecurity, and establishing and enhancing biosurveillance capacity, and assisted with the DoD’s response to the Ebola outbreak in Western Africa. Awards include being selected as a TED Fellow, a New Voices Fellow of the National Academies of Science, Engineering and Medicine, a Presidential Leadership Scholar, and Social Enablers top 100 most inspiring social entrepreneurs. Catharine is an advocate for women in STEM and has been a contributor to major social and media networks including TED-Ed, the Guardian and the UK Science and Innovation Network.

Dr. Danielle Bitterman is a physician-scientist in the Artificial Intelligence in Medicine Program at Mass General Brigham and the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She is an Assistant Professor of Radiation Oncology at Harvard Medical School. Her research is dedicated to translating advances in artificial intelligence to the cancer clinic. Her laboratory develops and clinically validates natural language processing technologies that converts information in electronic health records into intelligent systems that actively support patients, caregivers, and clinicians by facilitating communication, education, and data-driven insights. Dr. Bitterman received her undergraduate degree at Columbia University and attended medical school at New York University School of Medicine. She completed an internship in internal medicine at the Brigham and Women's Hospital, and her residency at the Harvard Radiation Oncology Program. She completed her post-doctoral fellowship in natural language processing at the Computational Health Informatics Program at Boston Children’s Hospital.

Dr. Gralow is the Chief Medical Officer (CMO) and Executive Vice President of ASCO, and brings to her role deep expertise in patient care, research, education, and global health. Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. Dr. Gralow is strongly committed to advancing equity in cancer care. As founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN), she supports patient advocates in low- and middle-resource countries. In addition, she served as an adjunct professor in the University of Washington’s Department of Global Health, as a member of the University of Washington’s Breast Cancer Equity Initiative, as Medical Director for Women’s Cancer-related Population Health at the University of Washington, and as an advisory council member for the Uganda Cancer Institute’s adult Hematology/Oncology Fellowship Training Program. Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally. She is a recognized leader in breast cancer clinical research, and has conducted clinical trials in breast cancer prevention, treatment, and survivorship. Dr. Gralow served in leadership roles for the SWOG Cancer Research Network funded by the National Cancer Institute (NCI), including as Vice Chair of the Breast Cancer Committee and Executive Officer of Breast and Lung Cancer. Before joining ASCO full-time, Dr. Gralow served the Society in a variety of volunteer and leadership roles, including chairing the ASCO Academic Global Oncology Task Force, co-chairing the ASCO Resource Stratified Guideline Advisory Group, and serving on the editorial board of the European Society of Medical Oncology (ESMO)/ASCO Global Curriculum in Medical Oncology. She also has been involved with numerous other nonprofit organizations, including Team Survivor Northwest, an exercise and fitness program for woman cancer survivors which she co-founded in 1995 and serves as Team Physician; a medical advisory committee member for Cierra Sisters African American Support Group; an advisory board member of Global Focus on Cancer; and a Board member of Peace Island Medical Center, a rural access hospital in Washington State. Dr. Gralow received her bachelor’s degree from Stanford University and her medical degree from the University of Southern California School of Medicine. She trained in internal medicine at Brigham and Women's Hospital at Harvard Medical School and completed a medical oncology fellowship at University of Washington/Fred Hutchinson Cancer Research Center in Seattle.

Dr. Jason Hipp, MD/PhD is the Chief Digital Innovation Officer for Mayo Collaborative Services (the commercial diagnostics arm of Mayo Clinic) and the Medical Director for Biopharma Diagnostics business unit.  He is a MD/PhD board certified pathologist with fellowship training in Informatics.  He has been active in the field of digital pathology for the past 13 years and has spent most of hist time in Industry, having worked at Novartis, BMS and AstraZeneca.  He was also the first pathologist hired by Alphabet and was the lead pathologist at Google.  He spent two years before his current role in Mayo Clinic’s Practice, where he was the founder and Chair of the Division of Computational Pathology & Artificial Intelligence.